The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Predicting relapse in Crohn’s disease: a biopsychosocial model
Abstract
Background: Crohn’s disease (CD) is a chronic relapsing inflammatory bowel disorder. Both biological and psychosocial factors may modulate the illness experience. Aim: The aim of this study was to identify clinical, biological and psychosocial parameters as predictors of clinical relapse in quiescent CD. Methods: Patients in medically induced remission were followed prospectively for 1 year, or less if they relapsed. Disease characteristics were determined at baseline. Serum cytokines, anti- Saccharomyces cerevisiae antibodies, C-reactive protein (CRP), erythrocyte sedimentation rate and intestinal permeability were measured every 3 months. Psychological distress, perceived stress, minor life stressors and coping strategies were measured monthly. A time-dependent multivariate Cox regression model determined predictors of time to relapse. Results: 101 patients (60 females, 41 males) were recruited. Fourteen withdrew and 37 relapsed. CRP (HR = 1.5 per 10 mg/l, 95% CI 1.1 to 1.9, p = 0.007), fistulising disease (HR = 3.2, 95% CI, 1.1 to 9.4, p = 0.04), colitis (HR = 3.5 95% CI 1.2 to 9.9, p = 0.02) and the interaction between perceived stress and avoidance coping (HR = 7.0 per 5 unit increase for both scales, 95% CI 2.3 to 21.8, p = 0.003) were predictors of earlier relapse. Conclusions: In quiescent CD, a higher CRP, fistulising disease behaviour and disease confined to the colon were independent predictors of relapse. Moreover, patients under conditions of low stress and who scored low on avoidance coping (ie, did not engage in social diversion or distraction) were least likely to relapse. This study supports a biopsychosocial model of CD exacerbation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When we restricted the analysis to include only the two studies that recruited patients in clinical remission,[20, 26] the risk of flare among those with symptoms of anxiety at baseline was significantly higher (RR = 1.80; 95% CI 1.242.61).”
From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]
In the citing paper
“The 13 eligible articles reported on 12 separate study populations,[11, 20-30, 33] containing 9192 patients.”
From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]
In the citing paper
“Study quality is provided in Supplementary Tables 1 and 2; five studies scored 7 or more on the NewcastleOttawa scale.[11, 20, 23, 24, 26]”
From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]
In the citing paper
“When data were pooled from five studies,[20, 26, 27, 29, 30] containing 1244 patients, the risk of developing a flare of disease activity was no higher among those with symptoms of anxiety at baseline (RR = 1.20; 95% CI 0.93-1.55), with moderate heterogeneity between studies ( I 2 =53.7%).”
From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]
In the citing paper
“When data were pooled from eight studies,[20-23, 26, 27, 29, 30] which included 7606 patients, symptoms of depression at baseline were associated with a significantly increased risk of flare of disease activity during longitudinal follow-up (RR = 1.60; 95% CI 1.212.12), with high heterogeneity between studies ( I 2 =73.5%)”
From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]
In the citing paper
“However, when the analysis was restricted to include only three studies that recruited only patients in clinical remission,[20, 23, 26] there was no longer a significant increase in risk (RR = 1.36; 95% CI 0.88-2.09).”
From Bidirectional brain-gut axis effects influence mood and prognosis in IBD: A systematic review and meta-analysis (2022) · cites this paper as [20]
Citations
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
The Need for a New Medical Model: A Challenge for Biomedicine
Engel, G. L. (1977) · Science · doi:10.1126/science.847460 · Cited by 12,887
(1988) · Cited by 4,111
Folkman, S., & Moskowitz, J. T. (2004) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.141456 · Cited by 3,485
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events
Kanner, A. D., Coyne, J. C., Schaefer, C. A., & Lazarus, R. S. (1981) · Journal of Behavioral Medicine · doi:10.1007/bf00844845 · Cited by 3,128
Loftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,106
Stress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190
Classification of Inflammatory Bowel Disease
Lennard‐Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,022
Cited by
Sorted by citations
Epidemiology and risk factors for IBD
Ananthakrishnan, A. N. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.34 · Cited by 1,741
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,595
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A. C. J., Ahmad, T., Arnott, I. D., Driscoll, R., Mitton, S. G., Orchard, T. R., Rutter, M. D., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,433
Assche, G. V., Dignass, A. U., Reinisch, W., van der Woude, C. J., Sturm, A., Vos, M. D., Guslandi, M., Oldenburg, B., Dotan, I., Marteau, P. R., et al. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.09.009 · Cited by 904
Self-citationParacellular permeability and tight junction regulation in gut health and disease
Horowitz, A., Chánez-Paredes, S. D., Haest, X., & Turner, J. R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00766-3 · Cited by 748
Brain–Gut Interactions in Inflammatory Bowel Disease
Bonaz, B. L., & Bernstein, C. N. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.003 · Cited by 667
Vanuytsel, T., van Wanrooy, S., Vanheel, H., Vanormelingen, C., Verschueren, S., Houben, E., Salim Rasoel, S., Tόth, J., Holvoet, L., Farré, R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305690 · Cited by 615
Importance of disrupted intestinal barrier in inflammatory bowel diseases
Salim, S. Y., & Söderholm, J. D. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21403 · Cited by 627
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000620 · Cited by 567
A comprehensive review and update on Crohn's disease
Gajendran, M., Loganathan, P., Catinella, A. P., & Hashash, J. G. (2017) · Disease-a-Month · doi:10.1016/j.disamonth.2017.07.001 · Cited by 553
Van Oudenhove, L., Levy, R. L., Crowell, M. D., Drossman, D. A., Halpert, A. D., Keefer, L., Lackner, J. M., Murphy, T. B., & Naliboff, B. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.027 · Cited by 512
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
Lewis, J. D. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.058 · Cited by 457
Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier
Al–Sadi, R., Khatib, K., Guo, S., Ye, D., Youssef, M., & Ma, T. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00055.2011 · Cited by 420
A prospective population-based study of triggers of symptomatic flares in IBD
Bernstein, C. N., Singh, S., Graff, L. A., Walker, J. R., Miller, N., & Cheang, M. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.140 · Cited by 400
Intestinal Permeability Defects: Is It Time to Treat?
Odenwald, M. A., & Turner, J. R. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.001 · Cited by 366
Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
Zhang, M., Sun, K., Wu, Y., Yang, Y., Tso, P., & Wu, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00942 · Cited by 347
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review
Abegunde, A. T., Muhammad, B. H., Bhatti, O. I., & Ali, T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i27.6296 · Cited by 250
Fairbrass, K. M., Lovatt, J., Barberio, B., Yuan, Y., Gracie, D. J., & Ford, A. C. (2022) · Gut · doi:10.1136/gutjnl-2021-325985 · Cited by 225
Doherty, G. A., Katsanos, K. H., Burisch, J. M., Allez, M., Papamichael, K., Stallmach, A., Mao, R., Berset, I. P., Gisbert, J. P., Sebastian, S., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx101 · Cited by 217
Biomarkers in inflammatory bowel disease: current practices and recent advances.
Iskandar, H. N., & Ciorba, M. A. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.001 · Cited by 210
“(39) In contrast, evaluations of ESR have shown only mixed results with regards to its ability to predict relapse.(37, 40)”
ResultPellissier, S., Dantzer, C., Mondillon, L., Trocme, C., Gauchez, A.-S., Ducros, V., Mathieu, N., Toussaint, B., Fournier, A., Canini, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105328 · Cited by 212
Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases
Rozich, J. J., Holmer, A. K., & Singh, S. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000608 · Cited by 216
Pellissier, S., Dantzer, C., Canini, F., Mathieu, N., & Bonaz, B. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.10.004 · Cited by 198
Langhorst, J., Wulfert, H., Lauche, R., Klose, P., Cramer, H., Dobos, G., & Korzenik, J. R. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju007 · Cited by 209
Goodhand, J. R., Wahed, M., Mawdsley, J. E., Farmer, A. D., Aziz, Q., & Rampton, D. S. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22916 · Cited by 234
Environmental Risk Factors for Inflammatory Bowel Diseases: A Review
Ananthakrishnan, A. N. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3350-9 · Cited by 196
Disease monitoring in inflammatory bowel disease
Chang, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11246 · Cited by 195
Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD?
Singh, S., Graff, L. A., & Bernstein, C. N. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.15 · Cited by 181
The epidemiology and risk factors of inflammatory bowel disease.
Ye, Y., Pang, Z., Chen, W., Ju, S., & Zhou, C. (2015) · PubMed Central · Cited by 180
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies
Caron, B., Honap, S., & Peyrin‐Biroulet, L. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae082 · Cited by 179
Ananthakrishnan, A. N., Khalili, H., Pan, A., Higuchi, L. M., de Silva, P., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.032 · Cited by 155
Positioning and usefulness of biomarkers in inflammatory bowel disease
Sakurai, T., & Saruta, M. (2023) · Digestion · doi:10.1159/000527846 · Cited by 156
Cohort Profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)
Pittet, V. E. H., Juillerat, P., Mottet, C., Felley, C., Ballabeni, P., Burnand, B., Michetti, P., Vader, J.-P., & the Swiss IBD Cohort Study Group (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn180 · Cited by 154
Environment and the Inflammatory Bowel Diseases
Frolkis, A. D., Dieleman, L. A., Barkema, H. W., Panaccione, R., Ghosh, S. K., Fedorak, R. N., Madsen, K., & Kaplan, G. G. (2013) · Canadian Journal of Gastroenterology · doi:10.1155/2013/102859 · Cited by 153
Mechanisms and Functional Implications of Intestinal Barrier Defects
Shen, L., Su, L., & Turner, J. R. (2009) · Digestive Diseases · doi:10.1159/000233282 · Cited by 149
Vagus Nerve Stimulation at the Interface of Brain–Gut InteractionsPreprint
Bonaz, B. L., Sinniger, V., & Sonia Pellissier, A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034199 · Cited by 151
How to predict clinical relapse in inflammatory bowel disease patients
Liverani, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1017 · Cited by 146
Torres, J., Ellul, P., Langhorst, J., Mikocka‐Walus, A. A., Acosta, M. B., Basnayake, C., Ding, N. S., Gilardi, D., Katsanos, K. H., Moser, G., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz051 · Cited by 143
Adolescents with IBD: The importance of structured transition care
Goodhand, J., Hedin, C. R. H., Croft, N. M., & Lindsay, J. O. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.03.015 · Cited by 129
Abraham, C., Abreu, M. T., & Turner, J. R. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.288 · Cited by 129
Common Symptoms and Stressors Among Individuals With Inflammatory Bowel Diseases
Singh, S. R. K., Blanchard, A. K., Walker, J. R., Graff, L. A., Miller, N., & Bernstein, C. N. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.05.016 · Cited by 128
Goodhand, J., Greig, F. I. S., Koodun, Y., McDermott, A., Wahed, M., Langmead, L., & Rampton, D. S. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21846 · Cited by 130
Stress Coping, Distress, and Health Perceptions in Inflammatory Bowel Disease and Community Controls
Graff, L. A., Walker, J. R., Clara, I. P., Lix, L. M., Miller, N., Rogala, L., Rawsthorne, P. E., & Bernstein, C. N. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.529 · Cited by 126
Psychiatric co‐morbidity is associated with increased risk of surgery in Crohn's disease
Ananthakrishnan, A. N., Gainer, V. S., Perez, R. G., Cai, T., Cheng, S. ‐., Savova, G., Chen, P., Szolovits, P., Xia, Z., De Jager, P. L., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12195 · Cited by 122
Environmental risk factors for inflammatory bowel disease.
Ananthakrishnan, A. N. (2013) · Europe PMC (PubMed Central) · Cited by 119
Jakobsen, C., Pærregaard, A., Munkholm, P., & Wewer, V. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.05.024 · Cited by 119
Environmental Triggers for Inflammatory Bowel Disease
Ananthakrishnan, A. N. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0302-4 · Cited by 119
Brooks, A. J., Smith, P. J., Cohen, R., COLLINS, P. D., Douds, A. C., Forbes, V., Gaya, D. R., Johnston, B. T., McKiernan, P. J., Murray, C. D., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313000 · Cited by 118
Barry, V., Stout, M. E., Lynch, M. E., Mattis, S., Tran, D., Antun, A., Ribeiro, M., Stein, S. F., & Kempton, C. (2020) · Journal of Health Psychology · doi:10.1177/1359105319842931 · Cited by 111
Reber, S. O. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.05.014 · Cited by 116
Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring
Benitez, J.-M., Meuwis, M., Reenaers, C., Kemseke, C. V., Meunier, P., & Louis, E. J. (2013) · Gut · doi:10.1136/gutjnl-2012-303957 · Cited by 112
The role of stress in the mosaic of autoimmunity: An overlooked association
Sharif, Κ., Watad, ., Coplan, L., Lichtbroun, B., Krosser, A., Lichtbroun, M., Bragazzi, N. L., Amital, H., Afek, A. B., & Shoenfeld, Y. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.04.005 · Cited by 118
Inflammatory bowel disease and anxiety: links, risks, and challenges faced
Selinger, C. P., & Bannaga, A. (2015) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s57982 · Cited by 109
Environmental Factors Affecting Inflammatory Bowel Disease: Have We Made Progress?
Lakatos, P. L. (2009) · Digestive Diseases · doi:10.1159/000228553 · Cited by 107
Cámara, R. J. A., Ziegler, R., Begré, S., Schoepfer, A. M., & von Känel, R. (2009) · Digestion · doi:10.1159/000226087 · Cited by 106
Nacul, L., O’Boyle, S., Palla, L., Nácul, F. E., Mudie, K., Kingdon, C. C., Cliff, J. M., Clark, T. G., Dockrell, H. M., & Lacerda, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00826 · Cited by 104
Bao, C., Liu, P., Liu, H. R., Wu, L. Y., Shi, Y., Chen, W. F., Qin, W., Lu, Y., Zhang, J. Y., Jin, X. M., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv057 · Cited by 99
Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease
Filipović, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3552 · Cited by 99
High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
Magro, F., Rodrigues‐Pinto, E., Santos‐Antunes, J., Boas, F. V., Lopes, S., Nunes, A. C. R., Dias, C. C., & Macedo, G. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.07.005 · Cited by 99
Influence of environmental factors in the development of inflammatory bowel diseases
Legaki, E. (2016) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v7.i1.112 · Cited by 94
Biomarkers in inflammatory bowel disease: a practical guide
Clough, J., Colwill, M., Poullis, A. P., Pollok, R., Patel, K., & Honap, S. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241251600 · Cited by 102
Tabibian, A., Tabibian, J. H., Beckman, L. J., Raffals, L. L., Papadakis, K. A., & Kane, S. V. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3471-1 · Cited by 89
Piche, T., Ducrotté, P., Sabate, J. M., Coffin, B., Zerbib, F., Dapoigny, M., Hua, M., Marine-barjoan, E., Dainese, R., & Hébuterne, X. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01502.x · Cited by 95
Langhorst, J., Hofstetter, A., Wolfe, F., & Häuser, W. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182a192ba · Cited by 85
Julio-Pieper, M., Bravo, J. A., Aliaga, E., & Gotteland, M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12950 · Cited by 84
Naliboff, B. D., Kim, S. E., Bolus, R. R., Bernstein, C. N., Mayer, E. A., & Chang, L. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.377 · Cited by 82
Sturm, A., Stallmach, A., Atreya, R. N., Bettenworth, D., Bokemeyer, B., Dignass, A. U., Ehehalt, R., Germer, C. T., Grunert, P., Helwig, U., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1713-3941 · Cited by 83
Lennon, E. M., Maharshak, N., Elloumi, H. Z., Borst, L. B., Plevy, S. E., & Moeser, A. J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182802a4e · Cited by 78
Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease.
Vedamurthy, A., & Ananthakrishnan, A. N. (2019) · Europe PMC (PubMed Central) · Cited by 73
Shaler, C. R., Parco, A. A., Elhenawy, W., Dourka, J., Jury, J., Verdu, E. F., & Coombes, B. K. (2021) · Nature Communications · doi:10.1038/s41467-021-26992-4 · Cited by 74
Martin, T. D., Chan, S. S. M., & Hart, A. R. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3437-3 · Cited by 73
Dragoni, G., Innocenti, T., & Galli, A. (2020) · Digestive Diseases · doi:10.1159/000511641 · Cited by 72
Otoni, C. C., Heilmann, R. M., García‐Sancho, M., Sainz, Á., Ackermann, M. R., Suchodolski, J. S., Steiner, J. M., & Jergens, A. E. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15123 · Cited by 70
Alexakis, C., Kumar, S., Saxena, S., & Pollok, R. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14171 · Cited by 69
Mood and nonmood components of perceived stress and exacerbation of Crohnʼs disease
Cámara, R. J. A., Schoepfer, A. M., Pittet, V., Begré, S., & von Känel, R. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21623 · Cited by 67
Does psychological counseling alter the natural history of inflammatory bowel disease?
Wahed, M., Corser, M., Goodhand, J., & Rampton, D. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21098 · Cited by 69
Fairbrass, K. M., Gracie, D. J., & Ford, A. C. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.014 · Cited by 63
Wilson, R. G., Stevens, B. W., Guo, A., Russell, C. N., Thornton, A., Cohen, M., Sturgeon, H. C., Giallourakis, C. C., Khalili, H., Nguyen, D. D., et al. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3580-5 · Cited by 59
Management of stress in inflammatory bowel disease: a therapeutic option?
Goodhand, J., Wahed, M., & Rampton, D. S. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.55 · Cited by 58
The Influence of Stress on the Development and Severity of Immune-Mediated Diseases
Rampton, D. S. (2011) · Journal of Rheumatology Supplement · doi:10.3899/jrheum.110904 · Cited by 51
Influence of environmental factors on the onset and course of inflammatory bowel disease
Dutta, A. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1088 · Cited by 51
Biegler, K. A., Anderson, A. K. L., Wenzel, L. B., Osann, K., & Nelson, E. L. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0008 · Cited by 48
Psychological factors and stress in inflammatory bowel disease
Triantafillidis, J. K., Merikas, E., & Gikas, A. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.13.4 · Cited by 50
Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway
Heydarpour, P., Rahimian, R., Fakhfouri, G., Khoshkish, S., Fakhraei, N., Salehi-Sadaghiani, M., Wang, H., Abbasi, A., Dehpour, A. R., & Ghia, J. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.004 · Cited by 49
Wintjens, D., de Jong, M. J., Jong, A. E. V. D. M., Romberg-Camps, M. J. L., Becx, M. C., Maljaars, J., Bodegraven, A. A. V., Mahmmod, N., Markus, T., Haans, J. J. L., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy177 · Cited by 48
Prenatal Maternal Stress Exacerbates Experimental Colitis of Offspring in Adulthood
Sun, Y., Xie, R., Lü, L., Jin, G., Zhou, B., Huang, H., Li, M., Yang, Y., Liu, X., Cao, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700995 · Cited by 49
Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
Wagatsuma, K., Yokoyama, Y., & Nakase, H. (2021) · Life · doi:10.3390/life11121375 · Cited by 52
Ferreira, I., Pickering, D., Troy, S., Croese, J., Loukas, A. C., & Navarro, S. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.42 · Cited by 46
Reddy, B. K., Delen, D., & Agrawal, R. K. (2018) · Health Informatics Journal · doi:10.1177/1460458217751015 · Cited by 44
Cho, C. W., You, M., Oh, C. H., Lee, C. K., & Moon, S. K. (2021) · Gut and Liver · doi:10.5009/gnl210118 · Cited by 43
ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease
Farraye, F. A., Melmed, G., Lichtenstein, G. R., Barnes, E. L., Limketkai, B. N., Caldera, F., & Kane, S. V. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003541 · Cited by 44
Bessissow, T., Chao, C., Lemieux, C., Restellini, S., Afif, W., Bitton, A., Lakatos, P. L., & Wild, G. (2019) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_566_18 · Cited by 43
Self-citationMikocka-Walus, A. A., Turnbull, D., Holtmann, G., & Andrews, J. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22850 · Cited by 41
Acute Stress Elicited by Bungee Jumping Suppresses Human Innate Immunity
van Westerloo, D. J., Choi, G., Löwenberg, E. C., Truijen, J., de Vos, A. F., Endert, E., Meijers, J. C. M., Zhou, L., Pereira, M. P., Queiroz, K. C. S., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00204 · Cited by 43
Melinder, C., Hiyoshi, A., Fall, K., Halfvarson, J., & Montgomery, S. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014315 · Cited by 40
Che, Z., Ye, Z., Zhang, X., Lin, B., Yang, W., Liang, Y., & Zeng, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952071 · Cited by 40
Viganò, C. A., Beltrami, M., Bosi, M. F., Zanello, R., Valtorta, M., & Maconi, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00324 · Cited by 42
Füchsl, A. M., Neumann, I. D., & Reber, S. O. (2013) · Endocrinology · doi:10.1210/en.2013-1742 · Cited by 39
Metadata
- Authors
- Bitton, A., Dobkin, P. L., Edwardes, M. D., Sewitch, M. J., Meddings, J. B., Rawal, S., Cohen, A., Vermeire, S., Dufresne, L., Franchimont, D., & Wild, G. E.
- Affiliations
- McGill University Health Centre (CA)
- University of Alberta (CA)
- Jewish General Hospital (CA)
- Universitair Ziekenhuis Leuven (BE)
- Douglas Mental Health University Institute (CA)
- Corresponding author
- Bitton, A
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2008-04-07
- Volume
- 57
- Issue
- 10
- Pages
- 1386-1392
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2028756447
- Cited by
- 254
- References
- 63
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 13 · 2023: 6 · 2022: 18 · 2021: 15 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 20 · 2016: 17 · 2015: 14 · 2014: 15 · 2013: 21 · 2012: 12
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- Crohn's disease, recurrence prediction, biopsychosocial model, C-reactive protein, perceived stress, avoidance coping, colitis, serum cytokines, ASCA, intestinal permeability, psychosocial factors
- MeSH terms
- Adult, Blood Sedimentation, C-Reactive Protein, Crohn Disease, Female, Humans, Male, Models, Psychological, Permeability, Predictive Value of Tests, Prospective Studies, Recurrence, Stress, Psychological, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review